We helped our client understand the patient and caregiver experience of those receiving hospital-level medical care at home.

We helped our client understand the various cost containment trends and measures impacting innovative pharmaceuticals in Europe.

We helped our client proactively assess and prepare for impending competition from one of the world's first biosimilar therapies.

We helped our client make strategic investment decisions in early immunology and inflammation assets.

We helped our client understand global health technology assessment (HTA) trends and develop strategies to advocate for informed decision-making across key markets.